查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762527

远距病人监护市场：产业趋势与全球预测 - 依软体类型、应用领域、治疗领域、产品/软体用途、商业模式、主要地区

Remote Patient Monitoring Market: Industry Trends and Global Forecasts -Distribution by Type of Software, Application Area, Therapeutic Area, Product / Software Purpose, Type of Business Model, and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

远距病人监护市场：概览

预计到2035年，全球远距病人监护市场规模将从目前的94亿美元成长至880亿美元，在预测期内，年复合成长率将达到25%。

市场规模与机会分析依下列参数细分：

软体类型

  • 系统即软体
  • 系统即服务

应用

  • 血糖
  • 血压
  • 体温
  • 心电图
  • 血氧饱和度
  • 呼吸速率
  • 其他

治疗领域

  • 心血管疾病
  • 传染病
  • 代谢性疾病
  • 肿瘤疾病
  • 呼吸系统疾病
  • 其他

产品/解决方案软体用途

  • 商业用途
  • 临床用途

商业模式

  • B2B
  • B2C

主要地区

  • 北美
  • 欧洲
  • 亚太地区
  • 中东和北非
  • 拉丁美洲

远距病人监护市场：成长与趋势

多年来，糖尿病、自体免疫疾病、心臟病等慢性疾病的盛行率疾病和癌症的发生率显着上升。事实上，根据密西根大学慢性病管理中心最近发布的报告，超过50%的美国人口患有某种慢性疾病。这迫切需要透过频繁的监测来管理疾病的迹象。然而，一些患者未能及时向医疗保健提供者报告他们的健康问题，导致严重后果并增加医疗保健成本。在此背景下，远端患者监控应运而生，成为一种潜在的解决方案，使医疗保健提供者能够在家庭护理环境中监测重要的健康体征。

远端病患监控市场-IMG1

远端病患监测（RPM）的概念始于近200年前的19世纪。然而，直到云端运算的出现，该领域才有了显着的发展。事实上，远距病患监护解决方案正逐渐融入医疗保健的主流，尤其是在新冠疫情封锁期间。这些先进的工具和软体解决方案使在此期间患者的健康监护成为可能，并显着简化了监护流程。这些先进的设备利用人工智慧和生物感测器即时监测生命体征，例如血氧值、血压、心率、呼吸频率、血糖值以及其他重要体征。目前，多家公司正致力于开发远距患者监护系统。

远距病患监护市场：关键洞察

本报告深入探讨了远距患者监护市场的现状，并识别了该行业的潜在成长机会。主要调查结果包括：

  • 目前，超过 170 家公司声称拥有提供用于各种应用领域的远距患者监护解决方案的必要能力。
  • 用于远距患者监护的工具/软体解决方案与各种类型的软体一起研发，目的是针对不同的治疗领域。
远端病人监护市场-IMG2
  • 为了获得竞争优势，远距病人监护解决方案开发商正积极致力于将高阶功能整合到其解决方案和合作伙伴产品中。
  • 多年来，业内参与者已达成多项协议，以进一步开发和改进其专有软体解决方案。
  • 为了支持该领域的持续创新，私人和公共投资者已进行总计 25亿美元的重大资本投资。
  • 由于新冠疫情期间各种远距病人监护解决方案的需求大幅成长，预计到2030年，整体市场将以超过25%的年复合成长率成长。
远端病人监护市场-IMG3
  • 预计机会将平均分布于各个应用领域、商业模式类型和主要地理区域。

远距病人监护市场：关键细分市场

依软体类型划分，市场分为系统即软体（SaaS）和系统即服务（SaaS）。目前，系统即软体（SaaS）细分市场在全球远距病人监护市场中占有最大占有率。此外，由于对基于云端的解决方案的需求不断成长，预计系统即服务（SaaS）细分市场中的远距病人监护市场将在预测期内实现最高的市场成长。

依应用领域划分，市场分为血糖、血压、体温、心电图、血氧饱和度、呼吸频率等。目前，心电图细分市场在全球远距病人监护市场中占有最大占有率。这是由于心血管疾病的盛行率不断上升，需要持续监测重要的健康参数。此外，心电图市场预计在预测期内将以更高的年复合成长率成长。

依治疗领域划分，市场分为心血管疾病、传染病、代谢性疾病、肿瘤疾病、呼吸系统疾病等。目前，代谢性疾病细分市场在全球远距病人监护市场中占有最大占有率。然而，预计肿瘤疾病细分市场在预测期内将以更高的年复合成长率成长。

依产品/软体用途，市场细分为商业用途及临床用途。目前，商业用途占据远距病人监护市场的最大占有率。然而，临床用途预计将展现最高的成长潜力，并且在预测期内，其年复合成长率将高于其他用途。

依商业模式类型，全球市场细分为B2C模式和B2B模式。目前，B2C和B2B市场各占市场占有率。然而，预计B2C远距病人监护在未来几年将显着成长。

依主要地区划分，市场细分为北美、欧洲、亚太地区、中东和北非以及拉丁美洲。目前，欧洲在全球远距病人监护市场占据主导地位，占据最大的收入占有率。此外，亚太地区市场在未来几年的年复合成长率可能会更高。

远距病患监护市场参与者

  • BioTelemetry
  • Braster
  • LeewayHertz
  • LifeWatch
  • Masimo
  • Medtronic
  • Siemens Healthineers
  • Transtek Medical.

目录

第1章 简介

第2章 执行摘要

第3章 简介

  • 章节概述
  • 简介
  • 远距病患监护的优势
  • 远距患者监护的局限性
  • 远距病患监护解决方案的监管考量
  • 结论

第4章 市场格局

  • 章节概述
  • 远距病患监护咨询工具与软体：市场格局
  • 远距病患监护咨询工具和软体：解决方案提供者格局

第5章 公司简介

  • 章节概览
  • 北美公司
    • BioTelemetry
    • LeewayHertz
    • Masimo
  • 欧洲公司
    • Braster
    • LifeWatch
    • Medtronic
    • Siemens Healthineers
  • 亚太地区公司
    • Transtek Medical

第6章 合作伙伴关係与合作

  • 章节概览
  • 合作伙伴关係模式
  • 远端病患监测咨询工具与软体供应商：近期合作伙伴关係与合作

第7章 融资与投资分析

  • 章节概述
  • 融资类型
  • 远距病人监护咨询工具和软体供应商：融资和投资分析
  • 结论

第8章 产品竞争力分析

第9章 成本节约分析

  • 章节概述
  • 关键假设与研究方法
  • 远距病人照护解决方案：整体成本节约潜力
  • 结论

第10章 市场预测

  • 章节概述
  • 预测研究方法与关键假设
  • 2035年全球远距病人监护咨询工具及软体供应商市场
  • 全球远距病人监护咨询工具和软体供应商市场：依应用领域
  • 全球远距病人监护咨询工具和软体供应商市场：依治疗领域
  • 全球远端患者监测咨询工具和软体供应商市场：依软体用途
  • 全球远端病患监测咨询工具和软体供应商市场：依商业模式
  • 全球远端患者监测咨询工具和软体供应商市场：依地区

第11章 COVID-19 疫情下的生物标记数位化解决方案市场对解决方案的影响

第12章 SWOT 分析

  • 章节概述
  • 优势
  • 劣势
  • 机会
  • 威胁
  • SWOT 因素比较

第13章 结论

第14章 访谈记录

第15章 附录1：表格资料

第16章 附录2：公司与组织清单

Product Code: RA100295

REMOTE PATIENT MONITORING MARKET: OVERVIEW

As per Roots Analysis, the global remote patient monitoring market is estimated to grow from USD 9.4 billion in the current year to USD 88.0 billion by 2035, at a CAGR of 25% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Software

  • System as a Software
  • System as a Service

Application Area

  • Blood Glucose
  • Blood Pressure
  • Body Temperature
  • Electrocardiogram
  • Oxygen Saturation
  • Respiration Rate
  • Others

Therapeutic Area

  • Cardiovascular Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others

Product / Software Purpose

  • Commercial Purpose
  • Clinical Purpose

Type of Business Model

  • B2B
  • B2C

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

REMOTE PATIENT MONITORING MARKET: GROWTH AND TRENDS

Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. In fact, a recent report from the Center for Managing Chronic Disease at the University of Michigan reported that over 50% of the US population is affected by some form of chronic disease. Consequently, there is an urgent need for frequent monitoring to manage disease indications. However, some patients fail to report health issues to healthcare providers in time, which can lead to severe consequences and increased healthcare costs. In this context, remote patient monitoring has emerged as a potential solution for healthcare providers that enables them to monitor vital health signs in home care settings.

Remote Patient Monitoring Market - IMG1

The initiation of the concept of remote patient monitoring system (RPM) started nearly 200 years ago in 1800s. However, it wasn't until the introduction of cloud computing that the domain evolved at a significant pace. In fact, remote patient monitoring system solutions were gradually integrated into mainstream healthcare, specifically during the COVID-19 induced lockdown. These advanced tools and software solutions enabled and eased monitoring of patient health significantly during that period. These advanced devices utilize AI and biosensors to monitor vital signs like oxygen levels, blood pressure, heart rate, respiratory rate, blood glucose level, and other key signs in real time. Presently, several companies are focused on the development of remote patient monitoring systems.

REMOTE PATIENT MONITORING MARKET: KEY INSIGHTS

The report delves into the current state of the remote patient monitoring market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • At present, more than 170 players claim to have the required capabilities to offer remote patient monitoring solutions for use across a range of application areas.
  • Tools / software solutions for remote patient monitoring are being investigated across different types of software and are designed to target different therapeutic areas.
Remote Patient Monitoring Market - IMG2
  • In order to gain a competitive edge, remote patient monitoring solution developers are actively undertaking initiatives to integrate advanced features in their respective solutions and affiliated offerings.
  • Over the years, industry players have established several deals to further advance the development / enable the improvement of their proprietary software solutions.
  • To support the ongoing innovation in this field, private and public investors have made substantial capital investments of worth USD 2.5 billion.
  • Given the favourable increase in demand for various remote patient monitoring solutions during the COVID-19 pandemic, the overall market is poised to grow at a CAGR of over 25%, till 2030.
Remote Patient Monitoring Market - IMG3
  • The projected opportunity is expected to be well distributed across different areas of application, types of business model and key geographical regions.

REMOTE PATIENT MONITORING MARKET: KEY SEGMENTS

System as a Software Segment holds the Largest Share of the Remote Patient Monitoring Market

Based on the type of software, the market is segmented into a system as a software and system as a service type of software. At present, the system as a software segment holds the maximum share of the global remote patient monitoring market. Further, the remote patient monitoring market for system as a service segment is expected to show the highest market growth potential during the forecast period owing to the growing demand for cloud-based solutions.

By Application Area, Electrocardiogram is the Fastest Growing Segment of the Global Remote Patient Monitoring Market

Based on the application area, the market is segmented into blood glucose, blood pressure, body temperature, electrocardiogram, oxygen saturation, respiration rate and others. At present, the electrocardiogram segment holds the maximum share of the global remote patient monitoring market. This can be attributed to the growing prevalence of cardiovascular disorders that require constant monitoring of vital health parameters. Moreover, the market for electrocardiogram segment is expected to grow at a higher CAGR during the forecast period.

By Therapeutic Area, Metabolic Disorders Segment Accounts for the Largest Share of the Global Remote Patient Monitoring Market

Based on the therapeutic area, the market is segmented into cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorders, and others. Currently, the metabolic disorders segment captures the highest proportion of the global remote patient monitoring market. However, the oncological disorders segment is expected to grow at a higher CAGR during the forecast period.

By Product / Software Purpose, Commercial Purpose Segment is Likely to Dominate the Remote Patient Monitoring Market

Based on the product / software purpose, the market is segmented into commercial purpose and clinical purpose. At present, the commercial purpose segment holds the maximum share of the remote patient monitoring market. However, the clinical purpose segment is expected to show the highest growth potential during the forecast period, growing at a higher CAGR, compared to the other segments.

B2C is the Fastest Growing Segment of the Global Remote Patient Monitoring Market

Based on the type of business model, the global market is segmented into B2C and B2B models. Currently, both B2C and B2B segments hold equal market share. However, the remote patient monitoring for B2C segment is expected to witness substantial growth in the coming years.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Currently, Europe dominates the global remote patient monitoring market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Remote Patient Monitoring Market

  • BioTelemetry
  • Braster
  • LeewayHertz
  • LifeWatch
  • Masimo
  • Medtronic
  • Siemens Healthineers
  • Transtek Medical.

REMOTE PATIENT MONITORING MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global remote patient monitoring market, focusing on key market segments, including [A] type of software, [B] application area, [C] therapeutic area, [D] product / software purpose, [E] type of business model and [F] key geographical regions.
  • Market Landscape: A comprehensive evaluation of the companies engaged in providing remote patient monitoring consultation tools and software, based on several relevant parameters, such as [A] year of establishment, [B] company size and [C] location of headquarters. Additionally, a comprehensive evaluation of consultation tools and software, based on several relevant parameters, such as [A] type of software, [B] area of application, [C] therapeutic areas, [D] product / software purpose, [E] type of telemedicine operation, [F] type of remote patient monitoring service and [G] type of business model.
  • Company Profiles: In-depth profiles of key players that are engaged in the development of remote patient monitoring software, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the remote patient monitoring market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] type of software, [E] most active players and [F] geographical distribution of the partnership activity.
  • Funding and Investments: An in-depth analysis of the fundings raised by remote patient monitoring companies, based on relevant parameters, such as [A] year of funding instances, [B] amount invested, [C] type of funding, [D] geographical analysis, [E] most active players and [F] most active investors.
  • Product Competitiveness Analysis: A comprehensive competitive analysis of remote patient monitoring software, examining factors, such as [A] supplier power and [B] key product-related specifications.
  • Cost Saving Analysis: A comprehensive analysis of cost saving potential associated with the use of remote patient monitoring consultation tools and software solutions, examining factors, such as [A] number of patient visits and [B] increase in efficiency by adoption of remote patient monitoring software solutions.
  • Case Study: An insightful discussion on how the COVID-19 pandemic impacted the remote patient monitoring software market, accompanied by information on the important initiatives that were undertaken by players to overcome the challenges faced due to the pandemic.
  • SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of remote patient monitoring market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Introduction to Telemedicine
    • 3.2.1. Store-and-Forward Telemedicine
    • 3.2.2. Real-Time Telemedicine
    • 3.2.3. Telemedicine in Remote Patient Monitoring
  • 3.3. Advantages of Remote Patient Monitoring
  • 3.4. Limitations Associated with Remote Patient Monitoring
  • 3.5. Regulatory Considerations for Remote Patient Monitoring Solutions
  • 3.6. Concluding Remarks

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Remote Patient Monitoring Consultation Tools and Software: Overall Market Landscape
    • 4.2.1. Analysis by Type of Software
    • 4.2.2. Analysis by Purpose of Software
    • 4.2.3. Analysis by Area of Application
    • 4.2.4. Analysis by Therapeutic Area
    • 4.2.5. Analysis by Type of Telemedicine Operation
    • 4.2.6. Analysis by Type of Remote Patient Monitoring Service Offered
    • 4.2.7. Analysis by Type of Business Model
  • 4.3. Remote Patient Monitoring Consultation Tools and Software: Solution Providers Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters

5. COMPANY PROFILES

  • 5.1. Chapter Overview
  • 5.2. Players based in North America
    • 5.2.1. BioTelemetry
      • 5.2.1.1. Company Overview
      • 5.2.1.2. Financial Information
      • 5.2.1.3. Software Portfolio
      • 5.2.1.4. Future Outlook
    • 5.2.2. LeewayHertz
      • 5.2.2.1. Company Overview
      • 5.2.2.2. Software Portfolio
      • 5.2.2.3. Future Outlook
    • 5.2.3. Masimo
      • 5.2.3.1. Company Overview
      • 5.2.3.2. Financial Information
      • 5.2.3.3. Software Portfolio
      • 5.2.3.4. Future Outlook
  • 5.3. Players based in Europe
    • 5.3.1. Braster
      • 5.3.1.1. Company Overview
      • 5.3.1.2. Software Portfolio
      • 5.3.1.3. Future Outlook
    • 5.3.2. LifeWatch
      • 5.3.2.1. Company Overview
      • 5.3.2.2. Software Portfolio
      • 5.3.2.3. Future Outlook
    • 5.3.3. Medtronic
      • 5.3.3.1. Company Overview
      • 5.3.3.2. Financial Information
      • 5.3.3.3. Software Portfolio
      • 5.3.3.4. Future Outlook
    • 5.3.4. Siemens Healthineers
      • 5.3.4.1. Company Overview
      • 5.3.4.2. Financial Information
      • 5.3.4.3. Software Portfolio
      • 5.3.4.4. Future Outlook
  • 5.4. Players based in Asia-Pacific
    • 5.4.1. Transtek Medical
      • 5.4.1.1. Company Overview
      • 5.4.1.2. Financial Information
      • 5.4.1.3. Software Portfolio
      • 5.4.1.4. Future Outlook

6. PARTNERSHIPS AND COLLABORATIONS

  • 6.1. Chapter Overview
  • 6.2. Partnership Models
  • 6.3. Remote Patient Monitoring Consultation Tools and Software Providers: Recent Partnerships and Collaborations
    • 6.3.1. Analysis by Year of Partnership
    • 6.3.2. Analysis by Type of Partnership
      • 6.3.2.1. Analysis by Year and Type of Partnership
      • 6.3.2.2. Analysis by Type of Partnership and Company Size
    • 6.3.3. Analysis by Type of Software
      • 6.3.3.1. Analysis by Year of Partnership and Type of Software
      • 6.3.3.2. Analysis by Type of Partnership and Type of Software
    • 6.3.4. Most Active Players: Analysis by Number of Partnerships
    • 6.3.5. Regional Analysis
      • 6.3.5.1. Intercontinental and Intracontinental Agreements

7. FUNDING AND INVESTMENT ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Types of Funding
  • 7.3. Remote Patient Monitoring Consultation Tools and Software Providers: Funding and Investment Analysis
    • 7.3.1. Analysis by Cumulative Year-wise Trend, Since 2015
    • 7.3.2. Analysis by Amount Invested
    • 7.3.3. Analysis by Type of Funding
      • 7.3.3.1. Analysis by Type of Venture Capital Round
    • 7.3.4. Analysis by Type of Software
    • 7.3.5. Analysis by Focus Area
    • 7.3.6. Analysis by Geography
    • 7.3.7. Most Active Players: Analysis by Number of Instances
    • 7.3.8. Most Active Players: Analysis by Amount Invested
    • 7.3.9. Most Active Investors: Analysis by Number of Instances
    • 7.3.10. Analysis by Year, Amount Invested and Type of Investor
  • 7.4. Concluding Remarks

8. PRODUCT COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Methodology
  • 8.3. Assumptions / Key Parameters
  • 8.4. Product Competitiveness: Software as a Service
  • 8.5. Product Competitiveness: Software as a System

9. COST SAVING ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Key Assumptions and Methodology
  • 9.3. Remote Patient Monitoring Solutions: Overall Cost Saving Potential
    • 9.3.1. Likely Cost Savings in North America, Till 2035
    • 9.3.2. Likely Cost Savings in Europe, Till 2035
    • 9.3.3. Likely Cost Savings in Asia, Till 2035
    • 9.3.4. Likely Cost Savings in Rest of the World, Till 2035
  • 9.4. Conclusion

10. MARKET FORECAST

  • 10.1. Chapter Overview
  • 10.2. Forecast Methodology and Key Assumptions
  • 10.3. Global Remote Patient Monitoring Consultation Tools and Software Providers Market, Till 2035
  • 10.4. Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Area of Application
    • 10.4.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Glucose, Till 2035
    • 10.4.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Pressure, Till 2035
    • 10.4.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for ECG, Till 2035
    • 10.4.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oxygen Saturation, Till 2035
    • 10.4.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiration Rate, Till 2035
    • 10.4.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Body Temperature, Till 2035
    • 10.4.7. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Areas of Application, Till 2035
  • 10.5. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Therapeutic Area
    • 10.5.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Cardiovascular Disorders, Till 2035
    • 10.5.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Infectious Diseases, Till 2035
    • 10.5.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for Metabolic Disorders, Till 2035
    • 10.5.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oncological Disorders, Till 2035
    • 10.5.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiratory Disorders, Till 2035
    • 10.5.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Therapeutic Areas, Till 2035
  • 10.6. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Purpose of Software
    • 10.6.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Clinical Studies, Till 2035
    • 10.6.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Commercial Purposes, Till 2035
  • 10.7. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Business Model
    • 10.7.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2B, Till 2035
    • 10.7.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2C, Till 2035
  • 10.8. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Geography
    • 10.8.1. Remote Patient Monitoring Consultation Tools and Software Providers Market in North America, Till 2035
    • 10.8.2. Remote Patient Monitoring Consultation Tools and Software Providers Market in Europe, Till 2035
    • 10.8.3. Remote Patient Monitoring Consultation Tools and Software Providers Market in Asia-Pacific, Till 2035
    • 10.8.4. Remote Patient Monitoring Consultation Tools and Software Providers Market in Middle East and North Africa (MENA), Till 2035
    • 10.8.5. Remote Patient Monitoring Consultation Tools and Software Providers Market in Latin America, Till 2035

11. IMPACT OF COVID-19 PANDEMIC ON DIGITAL SOLUTIONS FOR BIOMARKERS MARKET

  • 11.1. Chapter Overview
  • 11.2. Impact of COVID-19 on Telemedicine and Remote Patient Monitoring
    • 11.2.1. Impact on Future Market Opportunity for Remote Patient Monitoring
  • 11.3. Recuperative Initiatives of Key Players
  • 11.4. Recuperative Strategies for Businesses
    • 11.4.1. Strategies for Implementation in the Short / Mid Term
    • 11.4.2. Strategies for Implementation in the Long Term

12. SWOT ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Strengths
  • 12.3. Weaknesses
  • 12.4. Opportunities
  • 12.5. Threats
  • 12.6. Comparison of SWOT Factors

13. CONCLUSION

14. INTERVIEW TRANSCRIPTS

  • 14.1. Chapter Overview
  • 14.2. Company A
    • 14.2.1. Company Snapshot
    • 14.2.2. Survey Transcript

15. APPENDIX I: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 Remote Patient Monitoring Consultation Tools and Software: Information on Status of Software Development, Approved Countries, HIPAA Compliance and Software Specification
  • Table 4.2 Remote Patient Monitoring Consultation Tools and Software: Information on Area of Application
  • Table 4.3 Remote Patient Monitoring Consultation Tools and Software: Information on Therapeutic Area
  • Table 4.4 Remote Patient Monitoring Consultation Tools and Software: Information on Purpose of Software and Type of Business Model
  • Table 4.5 Remote Patient Monitoring Consultation Tools and Software: Information on Type of Telemedicine Operation and Patient Monitoring Related Services
  • Table 4.6 Remote Patient Monitoring Consultation Tools and Software: Information on Year of Establishment, Company Size and Location of Headquarters
  • Table 5.1 BioTel Care: Company Overview
  • Table 5.2 BioTel Care: Software Portfolio
  • Table 5.3 BioTel Care: Future Outlook
  • Table 5.4 LeewayHertz: Company Overview
  • Table 5.5 LeewayHertz: Software Portfolio
  • Table 5.6 Masimo: Company Overview
  • Table 5.7 Masimo: Software Portfolio
  • Table 5.8 Masimo: Future Outlook
  • Table 5.9 Braster: Company Overview
  • Table 5.10 Braster: Software Portfolio
  • Table 5.11 LifeWatch: Company Overview
  • Table 5.12 LifeWatch: Software Portfolio
  • Table 5.13 LifeWatch: Future Outlook
  • Table 5.14 Medtronic: Company Overview
  • Table 5.15 Medtronic: Software Portfolio
  • Table 5.16 Medtronic: Future Outlook
  • Table 5.17 Siemens Healthineers: Company Overview
  • Table 5.18 Siemens Healthineers: Software Portfolio
  • Table 5.19 Siemens Healthineers: Future Outlook
  • Table 5.20 Transtek Medical: Company Overview
  • Table 5.21 Transtek Medical: Software Portfolio
  • Table 5.22 Transtek Medical: Future Outlook
  • Table 6.1 Partnerships and Collaborations: Information on Partner, Year of Partnership, Type of Partnership and Type of Software, Since 2015
  • Table 7.1 Fundings and Investments: Information on Type of Funding, Year of Investment, Amount Invested and Lead Investors, Since 2015
  • Table 7.2 Funding and Investment Analysis: Summary of Investments
  • Table 7.3 Funding and Investment Analysis: Summary of Venture Capital Round
  • Table 7.4 Fundings and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Software, Type of Software, and Focus Area
  • Table 13.1 Remote Patient Monitoring Consultation Tools and Service Providers: List of RPM Software Focused on COVID-19 Patient Monitoring
  • Table 13.2 Remote Patient Monitoring Consultation Tools and Service Providers: Information on Partnerships Focused on COVID-19
  • Table 14.1 AltumView System: Company Snapshot
  • Table 15.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
  • Table 15.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
  • Table 15.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
  • Table 15.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
  • Table 15.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
  • Table 15.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
  • Table 15.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
  • Table 15.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
  • Table 15.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
  • Table 15.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
  • Table 15.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
  • Table 15.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
  • Table 15.13 Heat Map Representation: Distribution by Type of Software and Area of Application
  • Table 15.14 BioTel Care: Annual Revenues, Since 2015 (USD Million)
  • Table 15.15 Masimo: Annual Revenues, Since 2015 (USD Million)
  • Table 15.16 LifeWatch: Annual Revenues, Since 2015 (USD Million)
  • Table 15.17 Siemens Healthineers: Annual Revenues, Since 2015 (USD Million)
  • Table 15.18 Transtek Medical: Annual Revenues, Since 2015 (USD Million)
  • Table 15.19 Partnerships and Collaborations: Distribution by Year of Partnership
  • Table 15.20 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 15.21 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 15.22 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Table 15.23 Partnerships and Collaborations: Distribution by Type of Software
  • Table 15.24 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
  • Table 15.25 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
  • Table 15.26 Most Active Players: Distribution by Number of Partnerships
  • Table 15.27 Partnerships and Collaborations: Regional Distribution
  • Table 15.28 Partnerships and Collaborations: Country-wise Distribution
  • Table 15.29 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 15.30 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, Since 2015
  • Table 15.31 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
  • Table 15.32 Funding and Investment Analysis: Distribution by Type of Funding
  • Table 15.33 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
  • Table 15.34 Funding and Investment Analysis: Distribution by Year and Type of Funding
  • Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Table 15.36 Funding and Investment Analysis: Distribution by Type of Investor
  • Table 15.37 Funding and Investment Analysis: Distribution by Type of Software
  • Table 15.38 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
  • Table 15.39 Funding and Investment Analysis: Distribution by Focus Area
  • Table 15.40 Funding and Investment Analysis: Distribution by Geography
  • Table 15.41 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
  • Table 15.42 Most Active Players: Distribution by Number of Instances
  • Table 15.43 Most Active Players: Distribution by Amount Invested (USD Million)
  • Table 15.44 Most Active Investors: Distribution by Number of Instances
  • Table 15.45 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
  • Table 15.46 Overall Cost Saving Potential of Using Remote Patient Monitoring Solutions, Till 2035 (USD Million)
  • Table 15.47 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, Till 2035 (USD Million)
  • Table 15.48 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, Till 2035 (USD Million)
  • Table 15.49 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, Till 2035 (USD Million)
  • Table 15.50 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, Till 2035 (USD Million)
  • Table 15.51 Global Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market, Till 2035 (USD Million)
  • Table 15.52 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application
  • Table 15.53 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, Till 2035 (USD Million)
  • Table 15.54 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, Till 2035 (USD Million)
  • Table 15.55 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, Till 2035 (USD Million)
  • Table 15.56 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for ECG, Till 2035 (USD Million)
  • Table 15.57 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, Till 2035 (USD Million)
  • Table 15.58 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, Till 2035 (USD Million)
  • Table 15.59 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, Till 2035 (USD Million)
  • Table 15.60 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area
  • Table 15.61 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, Till 2035 (USD Million)
  • Table 15.62 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, Till 2035 (USD Million)
  • Table 15.63 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, Till 2035 (USD Million)
  • Table 15.64 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, Till 2035 (USD Million)
  • Table 15.65 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, Till 2035 (USD Million)
  • Table 15.66 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, Till 2035 (USD Million)
  • Table 15.67 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software
  • Table 15.68 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, Till 2035 (USD Million)
  • Table 15.69 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, Till 2035 (USD Million)
  • Table 15.70 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model
  • Table 15.71 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2B, Till 2035 (USD Million)
  • Table 15.72 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2C, Till 2035 (USD Million)
  • Table 15.73 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography
  • Table 15.74 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in North America, Till 2035 (USD Million)
  • Table 15.75 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Europe, Till 2035 (USD Million)
  • Table 15.76 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, Till 2035 (USD Million)
  • Table 15.77 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in MENA, Till 2035 (USD Million)
  • Table 15.78 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Latin America, Till 2035 (USD Million)
  • Table 15.79 Telemedicine in Remote Patient Monitoring Market, Till 2035: COVID-19 Impact Scenario (USD Million)

List of Figures

  • Figure 3.1 Type of Telemedicine
  • Figure 3.2 Steps Involved in Remote Patient Monitoring
  • Figure 3.3 Key Benefits and Limitations of RPM Solutions
  • Figure 4.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
  • Figure 4.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
  • Figure 4.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
  • Figure 4.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
  • Figure 4.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
  • Figure 4.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
  • Figure 4.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
  • Figure 4.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
  • Figure 4.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
  • Figure 4.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
  • Figure 4.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
  • Figure 4.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
  • Figure 4.13 Stacked Bar Chart Representation: Distribution by Type of Software and Area of Application
  • Figure 5.1 BioTel Care: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.2 Masimo: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.3 Medtronic: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.4 Siemens Healthineers: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.5 Transtek Medical: Annual Revenues, Since 2015 (USD Million)
  • Figure 6.1 Partnerships and Collaborations: Distribution by Year of Partnership
  • Figure 6.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 6.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 6.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Figure 6.5 Partnerships and Collaborations: Distribution by Type of Software
  • Figure 6.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
  • Figure 6.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
  • Figure 6.8 Most Active Players: Distribution by Number of Partnerships
  • Figure 6.9 Partnerships and Collaborations: Regional Distribution
  • Figure 6.10 Partnerships and Collaborations: Country-wise Distribution
  • Figure 6.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 7.1 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, Since 2015
  • Figure 7.2 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
  • Figure 7.3 Funding and Investment Analysis: Distribution by Type of Funding
  • Figure 7.4 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
  • Figure 7.5 Funding and Investment Analysis: Distribution by Year and Type of Funding
  • Figure 7.6 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Figure 7.7 Funding and Investment Analysis: Distribution by Type of Investor
  • Figure 7.8 Funding and Investment Analysis: Distribution by Type of Software
  • Figure 7.9 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
  • Figure 7.10 Funding and Investment Analysis: Distribution by Focus Area
  • Figure 7.11 Funding and Investment Analysis: Distribution by Geography
  • Figure 7.12 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
  • Figure 7.13 Most Active Players: Distribution by Number of Instances
  • Figure 7.14 Most Active Players: Distribution by Amount Invested (USD Million)
  • Figure 7.15 Most Active Investors: Distribution by Number of Instances
  • Figure 7.16 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
  • Figure 8.1 Product Competitiveness Analysis: Software as a Service
  • Figure 8.2 Product Competitiveness Analysis: Software as a System
  • Figure 9.1 Overall Cost Saving Potential Associated with Remote Patient Monitoring Solutions, Till 2035 (USD Million)
  • Figure 9.2 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, Till 2035 (USD Million)
  • Figure 9.3 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, Till 2035 (USD Million)
  • Figure 9.4 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, Till 2035 (USD Million)
  • Figure 9.5 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, Till 2035 (USD Million)
  • Figure 10.1 Global Remote Patient Monitoring Consultation Tools and Software Market, Till 2035 (USD Million)
  • Figure 10.2 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application
  • Figure 10.3 Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, Till 2035 (USD Million)
  • Figure 10.4 Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, Till 2035 (USD Million)
  • Figure 10.5 Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, Till 2035 (USD Million)
  • Figure 10.6 Remote Patient Monitoring Consultation Tools and Software Market for ECG, Till 2035 (USD Million)
  • Figure 10.7 Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, Till 2035 (USD Million)
  • Figure 10.8 Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, Till 2035 (USD Million)
  • Figure 10.9 Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, Till 2035 (USD Million)
  • Figure 10.10 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area
  • Figure 10.11 Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, Till 2035 (USD Million)
  • Figure 10.12 Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, Till 2035 (USD Million)
  • Figure 10.13 Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, Till 2035 (USD Million)
  • Figure 10.14 Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, Till 2035 (USD Million)
  • Figure 10.15 Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, Till 2035 (USD Million)
  • Figure 10.16 Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, Till 2035 (USD Million)
  • Figure 10.17 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software
  • Figure 10.18 Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, Till 2035 (USD Million)
  • Figure 10.19 Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, Till 2035 (USD Million)
  • Figure 10.20 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model
  • Figure 10.21 Remote Patient Monitoring Consultation Tools and Software Market for B2B, Till 2035 (USD Million)
  • Figure 10.22 Remote Patient Monitoring Consultation Tools and Software Market for B2C, Till 2035 (USD Million)
  • Figure 10.23 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography
  • Figure 10.24 Remote Patient Monitoring Consultation Tools and Software Market in North America, Till 2035 (USD Million)
  • Figure 10.25 Remote Patient Monitoring Consultation Tools and Software Market in Europe, Till 2035 (USD Million)
  • Figure 10.26 Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, Till 2035 (USD Million)
  • Figure 10.27 Remote Patient Monitoring Consultation Tools and Software Market in MENA, Till 2035 (USD Million)
  • Figure 10.28 Remote Patient Monitoring Consultation Tools and Software Market in Latin America, Till 2035 (USD Million)
  • Figure 11.1 Remote Patient Monitoring Market, Till 2035: COVID-19 Impact Scenario (USD Million)
  • Figure 11.2 Key RPM Consultation Tools and Software Providers
  • Figure 12.1 Remote Patient Monitoring Consultation Tools and Software Providers: SWOT Analysis
  • Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
  • Figure 13.1 Concluding Remarks: Current Market Landscape
  • Figure 13.2 Concluding Remarks: Recent Partnerships
  • Figure 13.3 Concluding Remarks: Funding Analysis
  • Figure 13.4 Concluding Remarks: Cost Saving Analysis
  • Figure 13.5 Concluding Remarks: Market Sizing and Opportunity Analysis
  • Figure 13.6 Concluding Remarks: Market Sizing and Opportunity Analysis by Geography